missing translation for 'onlineSavingsMsg'
Learn More

Selumetinib, MedChemExpress

Product Code. 16491916
Encompass_Preferred
Change view
Click to view available options
Mængde:
50 mg
100 mg
200 mg
500 mg
1 g
Unit Size:
1g
50mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Mængde unitSize
16491916 500 mg -
16474007 50 mg 50mg
16471316 200 mg -
16467856 100 mg -
16401939 1 g 1g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16491916 Supplier Medchem Express Supplier No. HY50706

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.

Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.

Specifications

Kemisk navn eller materiale Selumetinib
CAS 606143-52-6
Farve White
Renhedsgrad noter Research
Molekylær formel C17H15BrClFN4O3
Mængde 500 mg
Synonym AZD6244 ARRY-142886
Opløselighedsinformation DMSO : 10 mg/mL (21.85 mM; Need ultrasonic) ∣H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
SMIL O=C(C1=C(C(F)=C2N=CN(C2=C1)C)NC3=CC=C(C=C3Cl)Br)NOCCO
Molekylvægt (g/mol) 457.68
Formel vægt 457.68
Procent renhed 98.01%
Grad Research
Fysisk form Powder
Til brug med (applikation) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.